Ligament Tissue Engineering is an innovative and multidisciplinary approach aimed at developing strategies to repair or replace damaged ligaments through the use of engineered tissues. Injuries to ligaments, often resulting from trauma or sports-related activities, can lead to long-term joint instability and impaired function. Tissue engineering seeks to address these challenges by combining principles from engineering, biology, and materials science. Biomaterial scaffolds, made of biocompatible materials, serve as templates for cell attachment and tissue formation. Cells, often derived from the patient or from compatible sources, are seeded onto these scaffolds and encouraged to proliferate and differentiate into ligament-like tissue. Growth factors and mechanical stimulation are employed to mimic the natural microenvironment, promoting tissue development. Advances in tissue engineering also explore the integration of cells with synthetic or natural biomaterials to enhance the biomechanical properties of the engineered ligaments. While the field is making strides, challenges include achieving optimal scaffold design, cellular integration, and promoting long-term stability. Ligament tissue engineering holds promise for providing viable alternatives to conventional treatments, offering personalized solutions for ligament injuries and potentially revolutionizing the landscape of orthopedic medicine. Ongoing research continues to refine techniques and materials, aiming to bring effective ligament tissue engineering strategies into clinical practice.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States